Improving the Odds in Discriminating "Drug-like" from "Non Drug-like" Compounds

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of chemical information and computer sciences

• Publication date

  2000-10-04

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1021/ci0003810PMID 11128089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Molecular Modelling: Principles and Applications

  2001cited by this paper
• Bioinformatics - The Machine Learning Approach

  2000cited by this paper
• Identification of Biological Activity Profiles Using Substructural Analysis and Genetic Algorithms

  1998cited by this paper
• Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?

  1998cited by this paper
• A scoring scheme for discriminating between drugs and nondrugs.

  1998cited by this paper
• Artificial Neural Networks for Molecular Sequence Analysis

  1997cited by this paper
• A Pattern Classification Procedure Integrating the Multivariate Statistical Analysis with Neural Networks

  1997cited by this paper
• Data Processing in Chemistry with Neural Networks : An Alternate Way in Cases of Fuzzy Data or Incomplete Models

  1996cited by this paper
• PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules

  1996cited by this paper
• Automated analysis of nuclear magnetic resonance assignments for proteins.

  1995cited by this paper
• Neural networks in the search for similarity and structure — activity

  1995cited by this paper
• Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries.

  1994cited by this paper
• Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions.

  1994cited by this paper
• Prediction of protein secondary structure at better than 70% accuracy.

  1993cited by this paper
• Neural networks for control systems - A survey

  1992cited by this paper
• Prediction of human mRNA donor and acceptor sites from the DNA sequence.

  1991cited by this paper
• Applications of neural networks in quantitative structure-activity relationships of dihydrofolate reductase inhibitors.

  1991cited by this paper
• Parallel Distributed Processing: Explorations in the Micro-structure of Cognition

  1989cited by this paper
• Prediction of β-turns in proteins using neural networks

  1989cited by this paper
• Prediction of beta-turns in proteins using neural networks.

  1989cited by this paper
• Numerical Recipes: The Art of Scientific Computing

  1989cited by this paper
• Predicting the secondary structure of globular proteins using neural network models.

  1988cited by this paper
• Learning internal representations by error propagation

  1986cited by this paper
• Comparison of the predicted and observed secondary structure of T4 phage lysozyme.

  1975cited by this paper

• Comparative analysis of QSAR feature selection methods

  2024cites this paper
• Computational design of prospective molecular targets for Burkholderia cepacia complex by molecular docking and dynamic simulation studies

  2023cites this paper
• Scalable Inhibitors of the Nsp3–Nsp4 Coupling in SARS-CoV-2

  2023cites this paper
• Virtual screening of Indonesian herbal compounds as COVID-19 supportive therapy: machine learning and pharmacophore modeling approaches

  2022cites this paper
• Carbon fullerene and nanotube are probable binders to multiple targets of SARS-CoV-2: Insights from computational modeling and molecular dynamic simulation studies

  2021cites this paper
• Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies

  2021cites this paper
• In Silico ADME: Rule-Based Systems

  2021cites this paper
• Mitogen activated protein kinase-1 and cell division control protein-42 are putative targets for the binding of novel natural lead molecules: a therapeutic intervention against Candida albicans

  2020cites this paper
• Strategies of Virtual Screening in Medicinal Chemistry

  2020cites this paper
• Recent Perspectives on COVID-19 and Computer-Aided Virtual Screening of Natural Compounds for the Development of Therapeutic Agents Towards SARS-CoV-2

  2020cites this paper
• “Drug-likeness” properties of natural compounds

  2019cites this paper
• Prediction of binding potential of natural leads against the prioritized drug targets of chikungunya and dengue viruses by computational screening

  2018cites this paper
• “Drug-Likeness” versus “Natural Product-Likeness”

  2018cites this paper
• Model-Based Discovery of Synthetic Agonists for the Zn2+-Sensing G-Protein-Coupled Receptor 39 (GPR39) Reveals Novel Biological Functions.

  2017cites this paper
• Nanoparticle Fullerene (C60) demonstrated stable binding with antibacterial potential towards probable targets of drug resistant Salmonella typhi – a computational perspective and in vitro investigation

  2017cites this paper
• Discriminating Drug-Like Compounds by Partition Trees with Quantum Similarity Indices and Graph Invariants.

  2016cites this paper
• Secondary metabolites extracted from marine sponge associated Comamonas testosteroni and Citrobacter freundii as potential antimicrobials against MDR pathogens and hypothetical leads for VP40 matrix protein of Ebola virus: an in vitro and in silico investigation

  2016cites this paper
• Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.

  2016cites this paper
• Development of Computational Methods to Predict Protein Pocket Druggability and Profile Ligands using Structural Data

  2016cites this paper
• Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonists.

  2015cites this paper
• Machine Learning for Drug Design

  2015cites this paper
• Analysis of Drug Design for a Selection of G Protein-Coupled Neuro- Receptors Using Neural Network Techniques.

  2015cites this paper
• Compound Properties and their Influence on Drug Quality

  2015cites this paper
• Strategies in the Search for New Lead Compounds or Original Working Hypotheses

  2015cites this paper
• Computational Analysis of the Domain Architecture and Substrate-Gating Mechanism of Prolyl Oligopeptidases from Shewanella woodyi and Identification of Probable Lead Molecules

  2015cites this paper
• Sugar conjugates of 3-hydroxy-4-pyridinones : synthesis and investigations into their potential for drug delivery to the brain

  2015cites this paper
• The application of in silico drug-likeness predictions in pharmaceutical research.

  2015cites this paper
• Computational analysis of the domain architecture and substrate-gating mechanism of prolyl oligopeptidases from Shewanella woodyi and identification probable lead molecules

  2014cites this paper
• Compass: A hybrid method for clinical and biobank data mining

  2014cites this paper
• Exploring insights for virulent gene inhibition of multidrug resistant Salmonella typhi, Vibrio cholerae, and Staphylococcus areus by potential phytoligands via in silico screening

  2014cites this paper
• Computational Methods in Drug Discovery

  2014cites this paper
• Designing quantitative structure activity relationships to predict specific toxic endpoints for polybrominated diphenyl ethers in mammalian cells

  2014cites this paper
• Integrative Systems Approaches Towards Brain Pharmacology and Polypharmacology

  2013cites this paper
• DrugMint: a webserver for predicting and designing of drug-like molecules

  2013cites this paper
• SVM Based Descriptor Selection and Classification of Neurodegenerative Disease Drugs for Pharmacological Modeling

  2013cites this paper
• Classification models for safe drug molecules.

  2013cites this paper
• RECOGNIZING PATHOGENIC ANTIBODIES IN SLE USING GENERAL REGRESSION NEURAL NETWORKS

  2012cites this paper
• Chimiothèques ; vers une approche rationnelle de la sélection de sous-chimiothèques. (Chemical libraries ; towards a rational approach for the selection of sub-libraries)

  2011cites this paper
• Pharmacophore Models for Virtual Screening

  2011cites this paper
• QSAR-based permeability model for drug-like compounds.

  2011cites this paper
• An integrated drug-likeness study for bicyclic privileged structures: from physicochemical properties to in vitro ADME properties

  2011cites this paper
• Understanding drug‐likeness

  2011cites this paper
• In SilicoFragment-Based Generation of Drug-Like Compounds

  2011cites this paper
• Small molecule databases and chemical descriptors useful in chemoinformatics: an overview.

  2011cites this paper
• Discrimination of approved drugs from experimental drugs by learning methods

  2011cites this paper
• Atom type preferences, structural diversity, and property profiles of known drugs, leads, and nondrugs: a comparative assessment.

  2011cites this paper
• Natural Product-Like Virtual Libraries: Recursive Atom-Based Enumeration

  2011cites this paper
• Predicting Oral Druglikeness by Iterative Stochastic Elimination

  2010cites this paper
• Physicochemical Properties of Natural Based Products versus Synthetic Chemicals~!2010-03-18~!2010-04-26~!2010-06-09~!

  2010cites this paper
• QSAR-based solubility model for drug-like compounds.

  2010cites this paper
• Model-Free Drug-Likeness from Fragments

  2010cites this paper
• De novo design: balancing novelty and confined chemical space

  2010cites this paper
• Physicochemical Properties of Natural Based Products versus Synthetic Chemicals

  2010cites this paper
• In silico methods for the analysis of metabolites and drug molecules

  2010cites this paper
• Similarity methods in chemoinformatics

  2009cites this paper
• 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.

  2009cites this paper
• Drug-like and non drug-like pattern classification based on simple topology descriptor using hybrid neural network.

  2009cites this paper
• Physiochemical property space distribution among human metabolites, drugs and toxins

  2009cites this paper
• A comparative study on the molecular descriptors for predicting drug-likeness of small molecules

  2009cites this paper
• IN VIVO ANTILEISHMANIAL EFFICACY OF COMBRETASTATIN HETEROANALOGUES

  2009cites this paper
• FOG: Fragment Optimized Growth Algorithm for the de Novo Generation of Molecules Occupying Druglike Chemical Space

  2009cites this paper
• In silico prediction of drug properties.

  2009cites this paper
• A novel method for mining highly imbalanced high-throughput screening data in PubChem

  2009cites this paper
• Do Biologically Relevant Compounds Have More Chance To Be Drugs?

  2009cites this paper
• Aconitum and Delphinium alkaloids "Drug-likeness" descriptors related to toxic mode of action.

  2008cites this paper
• Development of Drug-likeness Model and Its Visualization

  2008cites this paper
• Consensual classification of drug/nondrug compounds for drug design (İlaç/ilaç olmayan bileşenlerin ilaç yapımı için ortak kararla sınıflanması)

  2008cites this paper
• Modeling anti-Trypanosoma cruzi Activity of N-Oxide Containing Heterocycles

  2008cites this paper
• ÇUKUROVA UNIVERSITY INSTITUTE OF NATURAL AND APPLIED SCIENCES

  2008cites this paper
• Consensual classification of drug and nondrug compounds

  2008influential citation
• Lead-Likeness and Drug-Likeness

  2008cites this paper
• Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes?

  2008cites this paper
• How large does a compound screening collection need to be?

  2008cites this paper
• Gradual in Silico Filtering for Druglike Substances

  2008cites this paper
• Recherche d'inhibiteurs de haute affinité de l'ADN polymérase bêta par criblage virtuel et RMN

  2008cites this paper
• Promiscuous Ligands

  2007cites this paper
• Design and synthesis of small nonpeptidergic ligands for the human cytomegalovirus-encoded receptor US28

  2007cites this paper
• A Large Descriptor Set and a Probabilistic Kernel-Based Classifier Significantly Improve Druglikeness Classification

  2007cites this paper
• Ligand efficiency indices for effective drug discovery

  2007cites this paper
• VIRTUAL SCREENING IN DRUG

  2007cites this paper
• Separating Drugs from Nondrugs: A Statistical Approach Using Atom Pair Distributions

  2007cites this paper
• Dielectric relaxation and crystallization of ultraviscous melt and glassy states of aspirin, ibuprofen, progesterone, and quinidine.

  2007cites this paper
• Virtual Screening in Drug Discovery

  2006cites this paper
• Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers

  2006cites this paper
• Bringing kinases into focus: efficient drug design through the use of chemogenomic toolkits.

  2006cites this paper
• Création et utilisation de chimiothèques optimisées pour la recherche in silico de nouveaux composés bioactifs

  2006cites this paper
• Diversity in medicinal chemistry space.

  2006cites this paper
• Can 'Bacterial-Metabolite-Likeness' Model Improve Odds of 'in Silico' Antibiotic Discovery?

  2006cites this paper
• FAF-Drugs: free ADME/tox filtering of compound collections

  2006cites this paper
• Privileged structures in GPCRs.

  2006cites this paper
• Collection and preparation of molecular databases for virtual screening

  2006cites this paper
• Effect of pressure on molecular and ionic motions in ultraviscous acetaminophen-aspirin mixture.

  2006cites this paper
• Computational chemistry-driven decision making in lead generation.

  2006cites this paper
• A New Rapid and Effective Chemistry Space Filter in Recognizing a Druglike Database

  2005cites this paper
• Drug design by machine learning: ensemble learning for QSAR modeling

  2005cites this paper
• Recent uses of topological indices in the development of in silico ADMET models.

  2005cites this paper
• Computational models to predict aqueous drug solubility, permeability and intestinal absorption

  2005cites this paper
• Ligand efficiency indices as guideposts for drug discovery.

  2005cites this paper
• Hierarchical docking of databases of multiple ligand conformations.

  2005cites this paper
• "In-House Likeness": Comparison of Large Compound Collections Using Artificial Neural Networks

  2005cites this paper